Cargando…
Transient cytotoxicity of (131)I beta radiation in hyperthyroid patients treated with radioactive iodine
BACKGROUND & OBJECTIVES: Radioiodine ((131)I) or radioactive iodine in low doses is used worldwide as the first line of management in the treatment of hyperthyroidism. Information is available on the extent and severity of cell damage after a high dose radioiodine ((131)I) therapy for thyroid ca...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103173/ https://www.ncbi.nlm.nih.gov/pubmed/21537093 |